美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

麥迪遜醫藥

84.90

0.0000

成交量：- -

成交額：- -

市值：67.88億

市盈率：-27.06

高：84.90

開：84.90

低：84.90

收：84.90

52周最高：84.98

52周最低：23.15

股本：7,994.83萬

流通股本：7,486.27萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-3.1374

每股收益(LYR):-1.6740

淨資產收益率：553.30%

總資產收益率：-13.71%

市淨率：178.02

市盈率(LYR):-50.72

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

高盛首予Revolution Medicines買入評級

华尔街洞察

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/MDCO"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDCO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCO\",,,,,undefined,":{"symbol":"MDCO","market":"US","secType":"STK","nameCN":"麥迪遜醫藥","latestPrice":84.9,"timestamp":1578085200000,"preClose":84.9,"halted":3,"volume":0,"delay":0,"floatShares":74862655,"shares":79948329,"eps":-3.137449,"marketStatus":"停牌","change":0,"latestTime":"01-03 16:00:00 EST","open":84.9,"high":84.9,"low":84.9,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.137449,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1762160400000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":965707200000,"exchange":"NASDAQ","adjPreClose":84.9,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCO\",,,,,undefined,":{"symbol":"MDCO","floatShares":74862655,"roa":"-13.71%","roe":"553.30%","lyrEps":-1.673974,"shares":79948329,"dividePrice":0,"high":84.9,"amplitude":0,"preClose":84.9,"low":84.9,"week52Low":23.15,"pbRate":"178.02","week52High":84.98,"institutionHeld":1.2829,"latestPrice":84.9,"eps":-3.137449,"divideRate":0,"volume":0,"delay":0,"ttmEps":-3.137449,"open":84.9,"prevYearClose":84.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCO\",params:#limit:5,,,undefined,":[{"date":"2019-10-30","symbol":"MDCO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.84,"defaultRemindTime":1572422400000,"name":null,"time":"盤前","dateTimestamp":1572408000000,"actualEps":null},{"date":"2019-07-24","symbol":"MDCO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.66,"defaultRemindTime":1563955200000,"name":null,"time":"盤前","dateTimestamp":1563940800000,"actualEps":-0.67},{"market":"US","date":"2019-04-25","symbol":"MDCO","fiscalQuarterEnding":"2019/03","expectedEps":-0.71,"name":null,"time":"盤前","type":"earning","dateTimestamp":1556164800000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2019-02-27","symbol":"MDCO","fiscalQuarterEnding":"2018/12","expectedEps":-0.35,"name":null,"time":"盤前","type":"earning","dateTimestamp":1551243600000,"reportTimeType":"pre","actualEps":-0.67},{"market":"US","date":"2018-11-08","symbol":"MDCO","fiscalQuarterEnding":"2018/09","expectedEps":-0.48,"name":null,"time":"盤前","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"pre","actualEps":-0.7}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDCO\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1147043564","title":"高盛首予Revolution Medicines買入評級","url":"https://stock-news.laohu8.com/highlight/detail?id=1147043564","media":"华尔街洞察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147043564?lang=zh_tw&edition=fundamental","pubTime":"2025-07-15 20:52","pubTimestamp":1752583959,"startTime":"0","endTime":"0","summary":"知名投行高盛日前发布研报，首次覆盖临床阶段生物医药公司Revolution Medicines，并给予\"买入\"评级。此次评级行动引发市场关注，投资者正重新评估该生物科技企业的研发管线价值。作为专注于肿瘤靶向疗法开发的创新企业，Revolution Medicines的核心在研药物涉及RAS信号通路抑制剂领域。高盛分析师在报告中强调，该公司差异化的研发策略与领先的临床数据，展现出突破现有治疗格局的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034235188.USD","IE00BSNM7G36.USD","LU2237438978.USD","LU0096364046.USD","LU1894683348.USD","LU2750360997.AUD","LU2471134952.CNY","BK4588","IE0004086264.USD","IE00BFXG1179.USD","LU0251142724.SGD","LU1868836591.USD","LU2750360641.GBP","LU1868837300.USD","LU1791807156.HKD","BK4127","LU2237443622.USD","LU0742534661.SGD","LU1868837136.USD","BK4139","LU0061475181.USD","LU0106831901.USD","LU1868836757.USD","LU1868836914.USD","BK4585","RVMD","LU1668664300.SGD","IE0004091025.USD","LU0251131958.USD","IE0002270589.USD","LU1894683264.USD","BK4533","BK4550","LU2237443978.SGD","LU2471134523.USD","LU0048573561.USD","BK4504","LU2237443895.HKD","LU2471134879.HKD","LU2471134796.USD","BK4516","BK4552","MDCO","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU2237443382.USD","LU2237443549.SGD","LU2237443465.HKD"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MDCO\",params:#limit:6,delay:false,,,undefined,":[]}}